(Q44003571)

English

Longitudinal follow-up of antibody response to selected antigens of human papillomaviruses and herpesviruses in patients with invasive cervical carcinoma

scientific article published in May 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Longitudinal follow-up of antibody response to selected antigens of human papillomaviruses and herpesviruses in patients with invasive cervical carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

author name string

E Hamsíková

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

V Ludvíková

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

J Kovarík

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

L Brousková

5

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

V Vonka

6

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

language of work or name

0 references

publication date

1 May 2000

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

86

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

351-355

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Humoral immune response against proteins E6 and E7 in cervical carcinoma patients positive for human papilloma virus type 16 during treatment and follow-up

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000501%2986%3A3%3C351%3A%3AAID-IJC8%3E3.0.CO%3B2-D

21 January 2018

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000501%2986%3A3%3C351%3A%3AAID-IJC8%3E3.0.CO%3B2-D

21 January 2018

Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000501%2986%3A3%3C351%3A%3AAID-IJC8%3E3.0.CO%3B2-D

21 January 2018

Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000501%2986%3A3%3C351%3A%3AAID-IJC8%3E3.0.CO%3B2-D

21 January 2018

Relationship of stable integration of herpes simplex virus-2 Bg/II N subfragment Xho2 to malignant transformation of human papillomavirus-immortalized cervical keratinocytes

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000501%2986%3A3%3C351%3A%3AAID-IJC8%3E3.0.CO%3B2-D

21 January 2018

Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against human papillomavirus antigens

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000501%2986%3A3%3C351%3A%3AAID-IJC8%3E3.0.CO%3B2-D

21 January 2018

The association of human papillomavirus type 16 E6 and E7 antibodies with stage of cervical cancer.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000501%2986%3A3%3C351%3A%3AAID-IJC8%3E3.0.CO%3B2-D

21 January 2018

Prevalence of antibodies to human papillomaviruses in the general population of the Czech Republic

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000501%2986%3A3%3C351%3A%3AAID-IJC8%3E3.0.CO%3B2-D

21 January 2018

Presence of antibodies to seven human papillomavirus type 16-derived peptides in cervical cancer patients and healthy controls

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000501%2986%3A3%3C351%3A%3AAID-IJC8%3E3.0.CO%3B2-D

21 January 2018

A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000501%2986%3A3%3C351%3A%3AAID-IJC8%3E3.0.CO%3B2-D

21 January 2018

Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000501%2986%3A3%3C351%3A%3AAID-IJC8%3E3.0.CO%3B2-D

21 January 2018

Comparison of ELISA and western blotting for human papillomavirus type 16 E7 antibody determination

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000501%2986%3A3%3C351%3A%3AAID-IJC8%3E3.0.CO%3B2-D

21 January 2018

Follow-up of antibody responses to human papillomavirus type 16 E7 in patients treated for cervical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000501%2986%3A3%3C351%3A%3AAID-IJC8%3E3.0.CO%3B2-D

21 January 2018

Serological response to HPV16 in CIN-III and cervical-cancer patients. Case-control studies in Spain and Colombia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000501%2986%3A3%3C351%3A%3AAID-IJC8%3E3.0.CO%3B2-D

21 January 2018

Disappearance of antibodies to HPV 16 E7 after treatment for cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000501%2986%3A3%3C351%3A%3AAID-IJC8%3E3.0.CO%3B2-D

21 January 2018

Serum antibody responses against human papillomavirus in relation to tumor characteristics, response to treatment, and survival in carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000501%2986%3A3%3C351%3A%3AAID-IJC8%3E3.0.CO%3B2-D

21 January 2018

Human papillomavirus DNA and antibodies to human papillomaviruses 16 E2, L2, and E7 peptides as predictors of survival in patients with squamous cell cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000501%2986%3A3%3C351%3A%3AAID-IJC8%3E3.0.CO%3B2-D

21 January 2018

Identifiers

10.1002/(SICI)1097-0215(20000501)86:3<351::AID-IJC8>3.0.CO;2-D

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44003571&oldid=2105557791"